<DOC>
	<DOCNO>NCT01096017</DOCNO>
	<brief_summary>This single blind , single dose , crossover study investigate relative efficacy terbutaline Turbuhaler® 0.4 mg relation salbutamol pressurize Metered Dose Inhaler ( pMDI ) 200 μg Japanese adult asthmatic patients.The secondary objective study investigate safety terbutaline Turbuhaler® 0.4 mg Japanese adult asthma patient mean adverse event ( AEs ) vital sign ( blood pressure , pulse rate ) . The subject population include Japanese patient ( 16 year age old ) asthma need treatment inhaled Glucocorticosteroids ( ICS ) .</brief_summary>
	<brief_title>To Investigate Relative Efficacy Terbutaline Turbuhaler® Salbutamol Pressurized Metered Dose Inhaler ( pMDI ) Single Blind Study</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>On ICS least 3 month Visit 2 prescribe constant dose 4 week prior Visit 2 Forced Expiratory Volume 1 Second ( FEV1 ) least 50 % predict normal value prebronchodilator Reversible airway obstruction accord reversibility test perform Visit 2 , define increase Forced Expiratory Volume 1 Second ( FEV1 ) ≥12 % relative baseline 1530 minute inhalation total 400 μg salbutamol Treatment oral , parenteral rectal GCS ( Glucocorticosteroids ) within 4 week depot parenteral GCS ( Glucocorticosteroids ) within 3 month prior Visit 2 . Change prescribe asthma medication due exacerbation asthma within 4 week prior Visit 2 hospitalize due exacerbation asthma within 8 week prior Visit 2 .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Terbutaline</keyword>
	<keyword>Turbuhaler</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Asthma</keyword>
	<keyword>Japanese</keyword>
	<keyword>salbutamol</keyword>
	<keyword>Bricanyl</keyword>
</DOC>